Cerebrospinal fluid excitatory amino acids and tau protein in children with acute lymphoblastic leukemia treated according to the BFM protocol

Acta Haematol. 2004;112(4):222-4. doi: 10.1159/000081278.
No abstract available

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Asparaginase / pharmacology
  • Asparaginase / therapeutic use*
  • Aspartic Acid / cerebrospinal fluid
  • Child
  • Daunorubicin / pharmacology
  • Daunorubicin / therapeutic use*
  • Excitatory Amino Acids / cerebrospinal fluid*
  • Glutamic Acid / cerebrospinal fluid
  • Humans
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / cerebrospinal fluid
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Prednisone / pharmacology
  • Prednisone / therapeutic use*
  • Vincristine / pharmacology
  • Vincristine / therapeutic use*
  • tau Proteins / cerebrospinal fluid*

Substances

  • Excitatory Amino Acids
  • tau Proteins
  • Aspartic Acid
  • Glutamic Acid
  • Vincristine
  • Asparaginase
  • Prednisone
  • Daunorubicin

Supplementary concepts

  • PVDA protocol